Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1988-02-19
1989-10-03
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
2603973, A61K 3156, C07J 100
Patent
active
048717258
ABSTRACT:
1-Methyl-15.alpha.-(1-oxyalkyl)androsta-1,4-diene-3,17-diones of general Formula I ##STR1## wherein R.sup.1 is a hydrogen atom or an acyl group of 1-10 carbon atoms,
REFERENCES:
patent: 3123622 (1964-03-01), Tweit
patent: 4202891 (1980-05-01), Schroepfer et al.
patent: 4289762 (1981-09-01), Metcalf et al.
Taber's Cyclopedic Medical Dictionary, Edition 13, Illustrated, p. M-9.
Brodie, A. M., et al., "Studies on the Mechanism of Estrogen Biosynthesis is in the Rat Ovary,", J. Steroid Biochem., 1976, vol. 7, pp. 787-791.
Henderson David
Kerb Ulrich
Nishino Yukishige
Lipovsky Joseph A.
Robinson Douglas W.
Schering Aktiengesellschaft
LandOfFree
1-methyl-15.alpha.-(1-oxyalkyl)androsta-1,4-diene-3,17-diones, p does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-methyl-15.alpha.-(1-oxyalkyl)androsta-1,4-diene-3,17-diones, p, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-methyl-15.alpha.-(1-oxyalkyl)androsta-1,4-diene-3,17-diones, p will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-664432